Seite 1 von 2

gemeinsame Leitlinie der

AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA 

zur Bewertung und Umgang mit dem Cholesterin im Blut

Deutsche Zusammenfassung auf:  https://www.gelbe-liste.de/kardiologie/cholesterol-leitlinie-kardiovaskulaeres-risiko-lipidsenker

 Quellen:

Grundy et al. (2018): AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, DOI: 10.1161/CIR.0000000000000624     =   https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000624

ACC/AHA 2018 Cholesterol Guideline: The New and the Old. Medscape, 2018 

Khera (2018): The New 2018 Cholesterol Guidelines. Circulation, DOI: 10.1161/CIRCULATIONAHA.118.038629

Lloyd-Jones et al. (2018): Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology, DOI: 10.1016/j.jacc.2018.11.005

Wilson et al. (2018): Systematic review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, DOI: 10.1016/j.jacc.2018.11.004

zudem: der

 ASCVD Risk estimator Plus des American College of Cardiology

auf  http://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/

Auf die Bedeutung des Cholesterins verwiesen wir bereits in unserem Beitrag:  Neuigkeiten 2017_11 CANTOS - Atherosklerose – Entzündungsprozesse